Vijay Kumar Rekulapally

Dr. Vijay Kumar Rekulapally

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

10 June 2022 in Journal of AOAC INTERNATIONAL
Verified
Journal Article
Closed access
PDF file
LKLeela Prasad Kowtharapu
Leela Prasad Kowtharapu
NKNaresh Kumar Katari
Naresh Kumar Katari
CSChristian A Sandoval
Christian A Sandoval
SMSiva Krishna Muchakayala
Siva Krishna Muchakayala
VRVijay Kumar Rekulapally
Vijay Kumar Rekulapally
Background: Dual therapeutic nature drug mast cell stabilizer and histamine receptor antagonist olopatadine hydrochloride (OPT) nasal spray does not have an official monograph, and no literature is available. Eye drops formulation had the official monograph for impurities, but the determination was done in two methods. Objective: A simple and effective green liquid chromatography method to develop and validate for the related substances of OPT nasal spray formulation. Method: A 25 min gradient method was employed to separate impurities and OPT with a 1.0 mL/min flow rate using a Boston green C8 (150 mm × 4.6 mm, 5 µm) HPLC column. The set wavelength and column oven temperatures were 299 nm and 30°C, respectively. pH 3.5 phosphate buffer–acetonitrile in the ratio of (70:30, v/v) as mobile phase A and (50:50, v/v) ratio as mobile phase B. A Quality by Design (QbD) based Design of Experiments (DoE) was employed to evaluate the robustness characteristics of the analytical method validation. Results: The obtained RSD from the precision and intermediate precision was 0.4 to 4.1%. The % recovery of the impurities from LOQ to 150% of specification level was 87.5 to 110.3%. The linear regression curves for the impurities with a correlation coefficient of >0.999 indicate that all peak responses are linear with the concentration. The sample and standard solutions were stable for 24 h at benchtop and refrigerator conditions. Conclusions: All the critical peaks were well separated from the forced degradation studies’ diluent, placebo, and generated degradation peaks. The method validation data and QbD based robustness study results indicate that the developed impurities method fits the routine quality control laboratory use. National Environmental Index (NMEI), Green Analytical Procedure Index (GAPI), Analytical Eco-scale and Analytical Greenness (AGREE) tools expressed the method’s greenness. Highlights: The proposed method is QbD utilized and green chemistry assessed impurities determination method for OPT in nasal spray formulation.

19 September 2021 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
RMRavindra Mallavarapu
Ravindra Mallavarapu
NKNaresh Kumar Katari
Naresh Kumar Katari
TDThirupathi Dongala
Thirupathi Dongala
VRVijay Kumar Rekulapally
Vijay Kumar Rekulapally
VMVishnu Murthy Marisetti
Vishnu Murthy Marisetti
GVGovind Vyas
Govind Vyas

1 January 2015 in Scientia Pharmaceutica
Verified
Journal Article
Open access
VRVijay Kumar Rekulapally
Vijay Kumar Rekulapally
A novel, stability-indicating, reversed-phase ultra-performance liquid chromatographic (RP-UPLC) method was developed for the determination of pure drotaverine hydrochloride and ibuprofen in the presence of their impurities and degradation products. The method was developed using a Waters UPLC BEH C18, 100 x 2.1 mm, 1.7 mu m column with a flow rate of 0.3 mL/min and detector wavelength at 210 nm. The mobile phase consisted of potassium dihydrogen orthophosphate buffer and acetonitrile. Drotaverine hydrochloride and ibuprofen were subjected to the stress conditions of oxidative, acid, base, photolytic, and thermal degradation. Degradation products resulting from the stress studies were well-resolved, thus confirming the test method as stability-indicating. Validation of the method was carried out as per International Conference on Harmonization guidelines.

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
MKMr.LEela Prasad Kowtharapu
Mr.LEela Prasad Kowtharapu
NKNaresh Kumar Katari
Naresh Kumar Katari
DSDr.CHristian A. Sandoval
Dr.CHristian A. Sandoval
MMMr.SIva Krishna Muchakayala
Mr.SIva Krishna Muchakayala
DCDr.RAjyalakshmi Ch
Dr.RAjyalakshmi Ch
VRVijay Kumar Rekulapally
Vijay Kumar Rekulapally
A lincosamide antibiotic injectable formulation contains clindamycin phosphate (CMN), benzyl alcohol (BAL), and Ethylenediaminetetraacetic acid (EDTA), all the contents were qualitatively and quantitatively determined by a single green liquid chromatography method. The three components were separated with Phenomenex prodigy C8 (250 mm x 4.6 mm, 5µm) HPLC column, flow rate 1.1 mL/min, injection volume 30 µL, and column temperature 35 °C. Lambda max 240 nm was set for the detection. 0.05M, pH 4.5 sodium acetate buffer with acetonitrile in the ratio of (80:20, v/v) were used. The method was validated as per ICH guidelines and proven that the method was specific, precise, accurate, and linear. Method robustness executed by utilizing quality by design experiment and concluded method is robust. Accuracy results were found 99.6 to 100.5 for CMN, 99.8 to 100.5 for BAL, and 99.2 to 100.1 for EDTA. Precision results were obtained % RSD 1.0% for CMN, 0.8% for BAL and 0.6% for EDTA. Correlation coefficient (r2) values obtained more than 0.999 for three components. Analytical solutions are stable for 48 hrs at benchtop and refrigerator conditions. Analytical method greenness was evaluated by utilizing the GAPI, NEMI, and analytical Eco-scale tools and confirmed the method is Eco-friendly.